Cargando…

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols

BACKGROUND: The study was designed to test the hypothesis that granulosa cell (GC) gene expression response differs between recombinant FSH and human menopausal gonadotropin (hMG) stimulation regimens. METHODS: Females < 35 years-old undergoing IVF for tubal or male factor infertility were prospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brannian, John, Eyster, Kathleen, Mueller, Breanne A, Bietz, Mandi G, Hansen, Keith
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842272/ https://www.ncbi.nlm.nih.gov/pubmed/20226040 http://dx.doi.org/10.1186/1477-7827-8-25

Ejemplares similares

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

Progressive obesity leads to altered ovarian gene expression in the Lethal Yellow mouse: a microarray study
por: Brannian, John, et al.
Publicado: (2009)

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population
por: Revelli, Alberto, et al.
Publicado: (2015)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

A Case of Suspected Isolated Follicle-Stimulating Hormone (FSH) Deficiency Where Spermatogenesis Was Acquired by Human Menopausal Gonadotropin (hMG)
por: Sugie, Miho, et al.
Publicado: (2023)

FSH regulates acetycholine production by ovarian granulosa cells
por: Mayerhofer, Artur, et al.
Publicado: (2006)

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
por: He, Bing, et al.
Publicado: (2015)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
por: Kirshenbaum, M., et al.
Publicado: (2021)

Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice
por: Brannian, John D, et al.
Publicado: (2008)

Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors
por: Haltia, Ulla-Maija, et al.
Publicado: (2020)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome
por: Rice, Suman, et al.
Publicado: (2013)

Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell Tumors
por: Matsuoka, Ayumu, et al.
Publicado: (2022)

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2014)

Association of GRIA1 polymorphisms with ovarian response to human menopausal gonadotropin in Iranian women
por: Golestanpour, Hossein, et al.
Publicado: (2020)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer
por: Zhang, Xiao-Jin, et al.
Publicado: (2015)

Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
por: Abazid, Rami Mahmood, et al.
Publicado: (2018)

Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis
por: Kim, Daham, et al.
Publicado: (2023)

OR33-3 Salt Inducible Kinase is a Negative Regulator of FSH in Ovarian Granulosa Cells
por: Armouti, Marah, et al.
Publicado: (2019)

Ovarian stimulation with human and recombinant gonadotropin – comparison of in vitro fertilization efficiency with use of time-lapse monitoring
por: Wdowiak, Artur, et al.
Publicado: (2015)

The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development
por: Wen, Xiaowei, et al.
Publicado: (2018)

DEHP Decreases Steroidogenesis through the cAMP and ERK1/2 Signaling Pathways in FSH-Stimulated Human Granulosa Cells
por: Tesic, Biljana, et al.
Publicado: (2023)

RAF1 mediates the FSH signaling pathway as a downstream molecule to stimulate estradiol synthesis and secretion in mouse ovarian granulosa cells
por: Luo, Xuan, et al.
Publicado: (2022)

Effects of human chorionic gonadotropin combined with clomiphene on Serum E(2), FSH, LH and PRL levels in patients with polycystic ovarian syndrome
por: Yonggang, Huang, et al.
Publicado: (2017)

Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins
por: Andersen, Claus Y, et al.
Publicado: (2014)

Ovarian responses and FSH profiles at superovulation with a single epidural administration of gonadotropin in the Thai-Holstein crossbreed
por: Chumchai, Rujira, et al.
Publicado: (2021)

Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats
por: TUNGMAHASUK, Doungrut, et al.
Publicado: (2017)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.
por: Chen, Mei-Jou, et al.
Publicado: (2015)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0ptcm5b9eb9303qao2kb2t2r5